Crestor
Product Images NDC 54868-5341

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Crestor (NDC 54868-5341). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Of 40 mg Package Label (1890)

Label for CRESTOR 40MG distributed by Physicians Total Care, Inc., Tulsa, OK. The label includes a lot number (000), an expiration date (01/60), and identifies manufacturing by IPR Pharmaceuticals LP. A barcode is also visible.*

FDA Label Image

Image Of 10 mg Package Label (4963)

Packaging label for CRESTOR 10 mg tablets by Physicians Total Care, Inc. The label indicates each tablet contains 10 mg of rosuvastatin calcium. The package holds 30 tablets. It includes dosage instructions and warnings, a barcode, lot number, and expiration date.*

FDA Label Image

Image Of 20 mg Package Label (5085)

CRESTOR 20 mg tablet bottle label from Physicians Total Care, Inc. The label indicates the labeler name, proprietary name, strength in milligrams, and count of 45 tablets. It contains dosing instructions, warnings about federal law restrictions, storage conditions, and barcodes with lot and expiration date information.*

FDA Label Image

Image Of 5 mg Package Label (5341)

CRESTOR 5 mg tablets label from Physicians Total Care, Inc. The white label shows the product name CRESTOR with the active ingredient Rosuvastatin Calcium. It contains 30 tablets with a strength of 5 mg each. The label also displays cautionary dispensing information, lot number, expiration date, storage instructions, and a barcode.*

FDA Label Image

Strucural Formula (Crestor Chem)

Chemical structure of the active ingredient corresponding to CRESTOR, shown as a calcium salt complex. The structure includes fluorophenyl, pyrimidine, and methylsulfonyl groups, highlighting the molecule's detailed chemical makeup.*

FDA Label Image

Figure One (Crestor Figone)

A box plot chart comparing the percent change from baseline in LDL-C for four different statins: Crestor, Atorvastatin, Simvastatin, and Pravastatin, across various doses measured in milligrams (10, 20, 40, and 80 mg where applicable). The vertical axis shows percent change from baseline LDL-C with values ranging from -75 to 0.*

FDA Label Image

Figure Three (Crestor Figthree)

A data table presenting the number of events comparison between Rosuva 20 mg and Placebo 20 mg across various cardiovascular endpoints, including primary endpoint, cardiovascular death, nonfatal stroke, nonfatal myocardial infarction, hospitalized unstable angina, and arterial revascularization. The table includes event rates, hazard ratios with 95% confidence intervals, and P values, alongside a hazard ratio plot spanning 0.1 to 10.*

FDA Label Image

Figure Two (Crestor Figtwo)

A cumulative incidence curve comparing Rosuva and Placebo groups over a period of 5 years. The chart shows cumulative incidence percentage on the y-axis and years on the x-axis, with Rosuva having a lower incidence than Placebo. Hazard ratio (HR) 0.56 with 95% confidence interval 0.46-0.69 and P value <0.001 are noted. Number at risk for both groups is listed below the x-axis.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.